Why the study?
Does early diagnostic ILR application allow safe and effective therapy in patients with recurrent suspected neurally mediated syncope?
Does early diagnostic ILR application allow safe and effective therapy in patients with recurrent suspected neurally mediated syncope?
Early application of an implantable loop recorder with delayed therapy until syncope documentation is a safe and effective strategy for patients with suspected neurally mediated syncope.
May support ILR-guided delayed therapy in recurrent NMS; hypothesis-generating and requires RCTs before practice change.
A strategy based on early diagnostic ILR application, with therapy delayed until documentation of syncope allows a safe, specific, and effective therapy in patients with NMS.
No takes yet. Share an insight, caveat, or question.
Brignole et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: